Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Toward future therapies in progressive supranuclear palsy

Identifieur interne : 004D81 ( Main/Merge ); précédent : 004D80; suivant : 004D82

Toward future therapies in progressive supranuclear palsy

Auteurs : David J. Burn [Royaume-Uni] ; Naomi M. Warren [Royaume-Uni]

Source :

RBID : ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8

English descriptors

Abstract

There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies. © 2005 Movement Disorder Society

Url:
DOI: 10.1002/mds.20546

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Toward future therapies in progressive supranuclear palsy</title>
<author>
<name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
</author>
<author>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20546</idno>
<idno type="url">https://api.istex.fr/document/F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E31</idno>
<idno type="wicri:Area/Istex/Curation">001E31</idno>
<idno type="wicri:Area/Istex/Checkpoint">002104</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16092097</idno>
<idno type="wicri:Area/PubMed/Corpus">002F30</idno>
<idno type="wicri:Area/PubMed/Curation">002F30</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F30</idno>
<idno type="wicri:Area/Ncbi/Merge">001382</idno>
<idno type="wicri:Area/Ncbi/Curation">001382</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001382</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
<idno type="wicri:Area/Main/Merge">004D81</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Toward future therapies in progressive supranuclear palsy</title>
<author>
<name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-08">2005-08</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">S12</biblScope>
<biblScope unit="supplement">S12</biblScope>
<biblScope unit="page" from="S92">S92</biblScope>
<biblScope unit="page" to="S98">S98</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8</idno>
<idno type="DOI">10.1002/mds.20546</idno>
<idno type="ArticleID">MDS20546</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adrenergic Agents (therapeutic use)</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Cholinergic Agents (therapeutic use)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Humans</term>
<term>Neurotransmitter Agents (therapeutic use)</term>
<term>Palliative Care</term>
<term>Steele–Richardson–Olszewski syndrome</term>
<term>Supranuclear Palsy, Progressive (drug therapy)</term>
<term>Supranuclear Palsy, Progressive (therapy)</term>
<term>progressive supranuclear palsy</term>
<term>treatment</term>
<term>trophic factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Adrenergic Agents</term>
<term>Anti-Dyskinesia Agents</term>
<term>Cholinergic Agents</term>
<term>Dopamine Agents</term>
<term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Palliative Care</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies. © 2005 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.20546">
<ISTEX>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Toward future therapies in progressive supranuclear palsy</title>
<author>
<name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
</author>
<author>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20546</idno>
<idno type="url">https://api.istex.fr/document/F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E31</idno>
<idno type="wicri:Area/Istex/Curation">001E31</idno>
<idno type="wicri:Area/Istex/Checkpoint">002104</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Toward future therapies in progressive supranuclear palsy</title>
<author>
<name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-08">2005-08</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">S12</biblScope>
<biblScope unit="supplement">S12</biblScope>
<biblScope unit="page" from="S92">S92</biblScope>
<biblScope unit="page" to="S98">S98</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8</idno>
<idno type="DOI">10.1002/mds.20546</idno>
<idno type="ArticleID">MDS20546</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Steele–Richardson–Olszewski syndrome</term>
<term>progressive supranuclear palsy</term>
<term>treatment</term>
<term>trophic factors</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies. © 2005 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Toward future therapies in progressive supranuclear palsy.</title>
<author>
<name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J" last="Burn">David J. Burn</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, UK. d.j.burn@ncl.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>University of Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M" last="Warren">Naomi M. Warren</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="doi">10.1002/mds.20546</idno>
<idno type="RBID">pubmed:16092097</idno>
<idno type="pmid">16092097</idno>
<idno type="wicri:Area/PubMed/Corpus">002F30</idno>
<idno type="wicri:Area/PubMed/Curation">002F30</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F30</idno>
<idno type="wicri:Area/Ncbi/Merge">001382</idno>
<idno type="wicri:Area/Ncbi/Curation">001382</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001382</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Toward future therapies in progressive supranuclear palsy.</title>
<author>
<name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J" last="Burn">David J. Burn</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, UK. d.j.burn@ncl.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>University of Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M" last="Warren">Naomi M. Warren</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adrenergic Agents (therapeutic use)</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Cholinergic Agents (therapeutic use)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Humans</term>
<term>Neurotransmitter Agents (therapeutic use)</term>
<term>Palliative Care</term>
<term>Supranuclear Palsy, Progressive (drug therapy)</term>
<term>Supranuclear Palsy, Progressive (therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Adrenergic Agents</term>
<term>Anti-Dyskinesia Agents</term>
<term>Cholinergic Agents</term>
<term>Dopamine Agents</term>
<term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Palliative Care</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D81 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004D81 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8
   |texte=   Toward future therapies in progressive supranuclear palsy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024